Omzo vs RxActivate: Compounded GLP-1 Plans and Pricing Differences
Quick verdict: For transparent starting pricing and an explicit compounded medication program, Omzo is clearer; RxActivate requires completing an eligibility flow and contact-info gate before revealing any price. This article compares Omzo vs RxActivate across program type, pricing transparency, clinician involvement, regulatory notes, and enrollment flow.
See Omzo clinician-guided plans
Program type and what each provider offers
Omzo: Clinician-guided GLP-1 care that connects users with licensed U.S. providers and a primary compounded medication program. Omzo states its compounded medications are prepared and shipped by a state licensed sterile compounding pharmacy and that those compounded drugs are not FDA approved. Providers can alternatively write prescriptions for branded medications, but Omzo does not sell or ship branded products.
RxActivate: Describes clinician-matched GLP-1 plans after a two minute eligibility questionnaire. The site notes treatment is available only when a licensed clinician determines it is medically appropriate. It also records that compounded medications, when offered, are not FDA approved and not reviewed by FDA for safety, effectiveness or quality.
Pricing transparency and enrollment flow
Direct comparison: Omzo publishes starting prices for its programs while RxActivate hides pricing behind an eligibility and contact gate. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. RxActivate requires completion of the intake questionnaire and submission of name, email, and phone before revealing any plan or price; no price or billing terms were displayed prior to that step.
| Criteria | Omzo | RxActivate |
|---|---|---|
| Program type | Clinician-guided; compounded meds primary; branded prescriptions possible | Clinician-matched plans after eligibility questionnaire |
| Pricing visibility | Starting prices published: semaglutide starting at $179; tirzepatide starting at $279 | Pricing gated; no price shown before contact-information step |
| Eligibility flow | Providers make final determination based on medical history and provider assessment | Two minute questionnaire requesting goals, history, state and safety screening |
| State availability | Users must confirm state availability before enrollment; provider networks of U.S. licensed clinicians | Alabama serviceability confirmed in a synthetic test; state screening in flow |
| Regulatory note | Compounded medications are not FDA approved and not reviewed by FDA for safety effectiveness or quality | Compounded medications when offered are not FDA approved and not reviewed by FDA for safety effectiveness or quality |
Clinician involvement and treatment decisions
Both Omzo and RxActivate rely on licensed clinicians to determine medical appropriateness. Omzo emphasizes clinician guided plans reviewed by licensed U.S. providers and notes that providers make the final determination as to whether to prescribe any medication. RxActivate also states treatment is available only when a licensed clinician determines it is medically appropriate and uses its eligibility flow to match users with clinicians.
Start RxActivate eligibility quiz
Enrollment experience and captured evidence
Omzo provides clear upfront product and price signals and includes marketing language describing patient experiences while noting results are not guaranteed. Omzo also clarifies it is not a medical practice and that clinical services are provided by third party clinician networks. RxActivate emphasizes its two minute questionnaire and notes that it requested contact information before revealing plan or price. RxActivate also displays a member claim of 250,000 plus members and uses state and medical safety screening in its flow.
Distinctive differences summarized
The most distinctive supported differences when comparing Omzo vs RxActivate are:
- Pricing transparency: Omzo lists starting prices; RxActivate hides pricing behind contact capture.
- Enrollment gate: RxActivate requires name email and phone before showing plans; Omzo provides more upfront details about programs and costs.
- Program framing: Omzo markets a primary compounded medication program with branded prescriptions as an alternative; RxActivate emphasizes clinician matching via a questionnaire.
- Documented state availability testing: RxActivate captured Alabama as serviceable in a synthetic test; Omzo requires users to confirm eligibility and state availability.
Proceed with RxActivate intake
Conclusion and who should choose which provider
Omzo vs RxActivate: choose based on how much upfront pricing and program detail you need. Choose Omzo if you want published starting prices and a clearly described compounded medication program with clinician-reviewed plans. Choose RxActivate if you are comfortable completing a two minute eligibility flow and providing contact information to learn specific pricing and plan details. Always confirm eligibility medication options total cost renewal terms and state availability before enrollment. The primary keyword Omzo vs RxActivate was used to compare pricing transparency enrollment flow clinician involvement and regulatory notes.